NKT cells: potential targets for autoimmune disease therapy?
about
Peripheral blood but not synovial fluid natural killer T cells are biased towards a Th1-like phenotype in rheumatoid arthritisThe stimulating adventure of KRN 7000.Alpha-galactosylceramide as a therapeutic agent for pulmonary Mycobacterium tuberculosis infection.The CD1 family and T cell recognition of lipid antigens.Beta-glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disordersNatural killer T cells as targets for immunotherapy of autoimmune diseases.Going both ways: immune regulation via CD1d-dependent NKT cells.alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles.Reduced proportions of natural killer T cells are present in the relatives of lupus patients and are associated with autoimmunity.Synthesis and evaluation of an acyl-chain unsaturated analog of the Th2 biasing, immunostimulatory glycolipid, OCH.Regulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis.Potential of targeting natural killer T cells for the treatment of autoimmune diseases.The potential role of iNKT cells in experimental allergic encephalitis and multiple sclerosis.What rheumatologists need to know about innate lymphocytes.The pro-fibrotic role of dipeptidyl peptidase 4 in carbon tetrachloride-induced experimental liver injury.Potential role of NKT regulatory cell ligands for the treatment of immune mediated colitis.Synthesis and evaluation of 3''- and 4''-deoxy and -fluoro analogs of the immunostimulatory glycolipid, KRN7000.Beta-glycoglycosphingolipid-induced alterations of the STAT signaling pathways are dependent on CD1d and the lipid raft protein flotillin-2.Induction of experimental allergic encephalomyelitis in a low-susceptible Albino Oxford rat strain by somatostatin analogue SMS 201-995.NK cell activation and protection occur independently of natural killer T cells during Trypanosoma cruzi infection.Beta-glycosphingolipids-mediated lipid raft alteration is associated with redistribution of NKT cells and increased intrahepatic CD8+ T lymphocyte trapping.Immune characterization of an individual with an exceptionally high natural killer T cell frequency and her immediate family.
P2860
Q24816601-0C1421A1-F7CD-4DF8-80CF-EAC9517AEF16Q33843406-6096B8C8-25A4-41F1-8BC5-97580B9C0FBFQ34172161-44D22E0F-661F-4B34-930B-B47D61EC73B5Q35030902-2FAC09C7-7AD4-4F31-AEA9-A383CDDE3B95Q35761273-6BFD8177-4FDB-494F-98B2-E8EE72C4435CQ35798168-102AA753-B35B-43A8-93A4-7C725A45D430Q35951531-8FEF05B4-043E-4A53-9C23-6E508B1DF193Q35998799-7654CD0D-C2BB-4657-83A0-0314435999DDQ36993238-9E5CCC35-7871-43FA-9689-C76C84ACB7DDQ37345148-1A2F8115-D601-421D-8B1D-3995444FC73DQ37834024-73BC33F2-D77D-4924-AE33-AC7DA67673CAQ38175496-45D4B8E7-D94E-4003-B954-A66CC1269E6CQ38193865-3908C86E-73E0-490C-946E-FB8629EFBDC7Q38809547-5E28C489-DC85-4DC2-9BBD-B0BF4A398E3FQ39144304-A99104D3-334F-4EA5-B67F-01E55FA9F365Q42954809-0F525739-457C-4C23-ACF7-63014D54E1BBQ43093958-3AA81517-EC0E-47BF-BE9B-FD1D1053C54EQ43143368-D37CC67F-6800-4914-8493-A37DF0B8C727Q46365861-66A455D5-1609-448C-8415-D68CA49FF0DBQ46414672-487313F2-4603-461B-B548-AAA3F3523D41Q46595862-D7A87519-CFCC-45EE-AEED-902BA8632B18Q51793903-A29C9F83-6D33-49BD-BC04-C4CCD4D6F8AB
P2860
NKT cells: potential targets for autoimmune disease therapy?
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
NKT cells: potential targets for autoimmune disease therapy?
@ast
NKT cells: potential targets for autoimmune disease therapy?
@en
NKT cells: potential targets for autoimmune disease therapy?
@nl
type
label
NKT cells: potential targets for autoimmune disease therapy?
@ast
NKT cells: potential targets for autoimmune disease therapy?
@en
NKT cells: potential targets for autoimmune disease therapy?
@nl
prefLabel
NKT cells: potential targets for autoimmune disease therapy?
@ast
NKT cells: potential targets for autoimmune disease therapy?
@en
NKT cells: potential targets for autoimmune disease therapy?
@nl
P2860
P1433
P1476
NKT cells: potential targets for autoimmune disease therapy?
@en
P2093
Godfrey DI
Hammond KJ
P2860
P304
P356
10.1034/J.1399-0039.2002.590501.X
P577
2002-05-01T00:00:00Z